Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer caused human death.
The majority of lung cancers are diagnosed at a late stage resulting in a 5 year survival rate (17 %) that is lower than breast (89 %), prostate (99%%), and colon carcinomas (65%%) [1].
In this study, we focused on the two datasets studying NSCLC, including lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD), because NSCLC accounts for the majority of lung cancer cases.
Interestingly, the majority of lung cancers in chromium workers were squamous cell carcinoma.
The majority of lung cancers (85%) are NSCLCs that include SCCs and adenocarcinomas [2].
A majority of lung TRM cells expressed at least one cytokine upon activation indicating that these cells were not anergic, and were capable of effector cytokine production.
This nc-rRNA was significantly more abundant in the majority of lung cancer cell lines, relative to a nontransformed lung epithelial cell line.
The majority of lung cancers are non-small-cell lung carcinoma (NSCLC), which is subdivided into adenocarcinoma (AC), squamous-cell carcinoma (SC), and large-cell carcinoma [2].
Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer and adenocarcinomas (AD) and squamous cell carcinomas (SCC) represent the most common types of NSCLC.
The vast majority of lung cancers are directly attributable to cigarette abuse [38]; furthermore, a substantial number of lung cancers in never-smokers are due to environmental tobacco exposure (passive smoking) [39].
By the end of the 30 minute monitoring period, the majority of lung function assessments for pigs in the probiotic-supplemented group were not different from those recorded as baseline while control animals failed to recover within this period.
